Institutional Ownership
Cytokinetics Inc
CUSIP 23282W605COM NEWCYTKQ1 2026
13D / 13G Filings
51
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
16.7%
Max % of class reported
Institutional Holders
429
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
51 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | T. Rowe Price Investment Management, Inc. | 13G/A | 14.5% | 17.72M | SEC |
| 2 | Nov 14, 2025 | T. Rowe Price Investment Management, Inc. | 13G/A | 16.0% | 19.10M | SEC |
| 3 | Nov 10, 2025 | State Street Corporation | 13G | 4.7% | 5.62M | SEC |
| 4 | Aug 14, 2025 | T. Rowe Price Investment Management, Inc. | 13G/A | 14.7% | 17.60M | SEC |
| 5 | Aug 7, 2025 | Fmr LLC | 13G/A | 10.9% | 13.10M | SEC |
| 6 | May 7, 2025 | T. Rowe Price Investment Management, Inc. | 13G | 11.3% | 13.42M | SEC |
| 7 | Feb 12, 2025 | Fmr LLC | 13G/A | 9.4% | 11.15M | SEC |
| 8 | Jan 8, 2025 | The Vanguard Group | 13G/A | 10.1% | 11.92M | SEC |
| 9 | Nov 14, 2024 | T. Rowe Price Investment Management, Inc. | 13G | 8.2% | 9.69M | SEC |
| 10 | Nov 12, 2024 | Blackrock, Inc. | 13G/A | 13.0% | 15.25M | SEC |
41 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cytokinetics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 16.55M | $1.09B |
| 2 | Fmr LLC | 10.72M | $706.76M |
| 3 | Wellington Management Group LLP | 8.01M | $527.91M |
| 4 | State Street Corp | 5.75M | $378.67M |
| 5 | Avoro Capital Advisors LLC | 3.33M | $219.70M |
| 6 | Geode Capital Management, LLC | 3.22M | $211.97M |
| 7 | Bank Of America Corp /De/ | 3.13M | $206.00M |
| 8 | Rtw Investments, LP | 2.72M | $179.35M |
| 9 | Goldman Sachs Group Inc | 2.21M | $145.38M |
| 10 | Ubs Group AG | 2.08M | $136.91M |